Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin vs Erythromycin for PPROM
NCT05328817Unknown
- Sponsor
- Eastern Virginia Medical School
- Start
- May 2022
- Primary completion
- May 2025
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of azithromycin in preterm premature rupture of membranes (pPROM) (2 arms), sponsored by Eastern Virginia Medical School. Primary endpoint: Latency Period. Status: unknown.
02
Drugs
azithromycin
03
Conditions
preterm premature rupture of membranes (pPROM)
Beyond the preview
Go deeper on NCT05328817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05328817.